NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Eloxx Pharmaceuticals Inc (NQ: ELOX)
6.490 USD  +0.040 (+0.62%)
Official Closing Price  /  Updated: 3:59 PM EDT, Sep 17, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 71,410
Open 6.430
Bid (Size) 6.490 (16)
Ask (Size) 6.540 (1)
Prev. Close 6.450
Today's Range 6.300 - 6.730
52wk Range 5.140 - 17.50
Shares Outstanding 33,427,238
Dividend Yield N/A
Performance
YTD
-53.44%
-53.44%
1 Month
+3.67%
+3.67%
3 Month
-35.10%
-35.10%
6 Month
-50.83%
-50.83%
1 Year
-54.17%
-54.17%
Top News
More News
Eloxx Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on October 3rd, 2019
from GlobeNewswire News Releases
Eloxx Pharmaceuticals to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Diseases on September 24, 2019
from GlobeNewswire News Releases
More News
Read More
Eloxx Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 5th, 2019
from GlobeNewswire News Releases
Eloxx Pharmaceuticals Announces Two Abstracts Accepted for Presentation at the American Society of Nephrology (ASN) Kidney Week 2019
from GlobeNewswire News Releases
Eloxx Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results and Provides Business Update
from GlobeNewswire News Releases
Eloxx Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial for ELX-02 in Cystinosis
from GlobeNewswire News Releases
Eloxx Pharmaceuticals Announces Open Investigational New Drug Application (IND) for a Phase 2 Clinical Trial of ELX-02 in Cystic Fibrosis Patients with the G542X Mutation in the US and Protocol Endors
from GlobeNewswire News Releases
Adding Up The Components: Russell 2000 Could Rise 22%
category ETFs
from ETF Channel
Eloxx Pharmaceuticals, Inc. (ELOX) Q2 2019 Earnings Call Transcript
category ELOX , Market News
from Motley Fool
Analysts Predict 30% Upside For The Holdings of BIB
category ETFs
from ETF Channel
Benzinga's Top Upgrades, Downgrades For September 6, 2019
category CGBD , ETR , NRZ , and 64 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.